Product
HS-10390
1 clinical trial
2 indications
Indication
IgA NephropathyIndication
focal segmental glomerulosclerosisClinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Studyto Evaluate the Safety, Tolerability and Pharmacokinetics of HS-10390 in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-02-16